| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants
|
Fujihashi, Kohtaro
|
|
2002
|
20 |
19-20 |
p. 2431-2438
8 p.
|
article
|
| 2 |
Antibody responses induced by immunization with a Japanese rabies vaccine determined by neutralization test and enzyme-linked immunosorbent assay
|
Arai, Yohko T.
|
|
2002
|
20 |
19-20 |
p. 2448-2453
6 p.
|
article
|
| 3 |
Avidity maturation following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine in UK infants
|
Longworth, Emma
|
|
2002
|
20 |
19-20 |
p. 2592-2596
5 p.
|
article
|
| 4 |
Characterization of a vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate
|
Lin, Ya-Ching
|
|
2002
|
20 |
19-20 |
p. 2485-2493
9 p.
|
article
|
| 5 |
Clinical and serological studies on CAM-70 live attenuated measles vaccine: an 18-year survey at a pediatric clinic in Japan
|
Ozaki, Takao
|
|
2002
|
20 |
19-20 |
p. 2618-2622
5 p.
|
article
|
| 6 |
Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol
|
Waag, David M
|
|
2002
|
20 |
19-20 |
p. 2623-2634
12 p.
|
article
|
| 7 |
Development of a high-performance anion-exchange chromatography with pulsed-amperometric detection based quantification assay for pneumococcal polysaccharides and conjugates
|
Talaga, Philippe
|
|
2002
|
20 |
19-20 |
p. 2474-2484
11 p.
|
article
|
| 8 |
Economic evaluation of strategies for the control and management of influenza in Europe
|
Scuffham, P.A.
|
|
2002
|
20 |
19-20 |
p. 2562-2578
17 p.
|
article
|
| 9 |
Effective synthetic peptide vaccine for foot-and-mouth disease in swine
|
Wang, Chang Yi
|
|
2002
|
20 |
19-20 |
p. 2603-2610
8 p.
|
article
|
| 10 |
Effects of adsorption of acellular pertussis antigens onto different aluminium salts on the protective activity in an intranasal murine model of Bordetella pertussis infection
|
Denoël, P
|
|
2002
|
20 |
19-20 |
p. 2551-2555
5 p.
|
article
|
| 11 |
Efficacy and cost-effectiveness of influenza vaccination of the elderly in a densely populated and unvaccinated community
|
Wang, Chong-Shan
|
|
2002
|
20 |
19-20 |
p. 2494-2499
6 p.
|
article
|
| 12 |
Efficacy of a B virus gD DNA vaccine for induction of humoral and cellular immune responses in Japanese macaques
|
Hirano, Makoto
|
|
2002
|
20 |
19-20 |
p. 2523-2532
10 p.
|
article
|
| 13 |
Evaluation of adverse effects of vaccines: the case-control approach
|
Smeeth, Liam
|
|
2002
|
20 |
19-20 |
p. 2611-2617
7 p.
|
article
|
| 14 |
Experimental studies with foot-and-mouth disease virus, strain O, responsible for the 2001 epidemic in the United Kingdom
|
Aggarwal, N.
|
|
2002
|
20 |
19-20 |
p. 2508-2515
8 p.
|
article
|
| 15 |
Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox
|
Brisson, M.
|
|
2002
|
20 |
19-20 |
p. 2500-2507
8 p.
|
article
|
| 16 |
Identification of Brucella melitensis vaccine strain Rev.1 by PCR-RFLP based on a mutation in the rpsL gene
|
Cloeckaert, Axel
|
|
2002
|
20 |
19-20 |
p. 2546-2550
5 p.
|
article
|
| 17 |
Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/AS04, a hepatitis B vaccine with a novel adjuvant
|
Desombere, Isabelle
|
|
2002
|
20 |
19-20 |
p. 2597-2602
6 p.
|
article
|
| 18 |
Induction of HLA-A2-restricted CTL responses by a tubular structure carrying human melanoma epitopes
|
Ghosh, Mrinal K.
|
|
2002
|
20 |
19-20 |
p. 2463-2473
11 p.
|
article
|
| 19 |
Influenza and pneumococcal vaccination in Scottish nursing homes: coverage, policies and reasons for receipt and non-receipt of vaccine
|
Kyaw, Moe H.
|
|
2002
|
20 |
19-20 |
p. 2516-2522
7 p.
|
article
|
| 20 |
Intranasal immunization with SIV virus-like particles (VLPs) elicits systemic and mucosal immunity
|
Yao, Qizhi
|
|
2002
|
20 |
19-20 |
p. 2537-2545
9 p.
|
article
|
| 21 |
Long term (24 months) follow-up of a hepatitis A and B vaccine, comparing a two and three dose schedule in adolescents aged 12–15 years
|
Levie, K.
|
|
2002
|
20 |
19-20 |
p. 2579-2584
6 p.
|
article
|
| 22 |
Private demand for a HIV/AIDS vaccine: evidence from Guadalajara, Mexico
|
Whittington, Dale
|
|
2002
|
20 |
19-20 |
p. 2585-2591
7 p.
|
article
|
| 23 |
Production and immunogenic efficacy of botulinum tetravalent (A, B, E, F) toxoid
|
Torii, Yasushi
|
|
2002
|
20 |
19-20 |
p. 2556-2561
6 p.
|
article
|
| 24 |
Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8+ T lymphocyte activation
|
Rafati, Sima
|
|
2002
|
20 |
19-20 |
p. 2439-2447
9 p.
|
article
|
| 25 |
Reduction of animal use in human vaccine quality control: opportunities and problems
|
Metz, Bernard
|
|
2002
|
20 |
19-20 |
p. 2411-2430
20 p.
|
article
|
| 26 |
The effectiveness of serogroup C meningococcal vaccine estimated from routine surveillance data
|
Rivest, Paul
|
|
2002
|
20 |
19-20 |
p. 2533-2536
4 p.
|
article
|
| 27 |
Vaccination of cats with an attenuated recombinant myxoma virus expressing feline calicivirus capsid protein
|
McCabe, Victoria J.
|
|
2002
|
20 |
19-20 |
p. 2454-2462
9 p.
|
article
|
Journal description